Esophageal Cancer Global Burden Profiles, Trends, and Contributors

Overview

Journal Cancer Biol Med

Specialty Oncology

Date 2024 Jul 27

PMID 39066471

Authors

Yi Teng

Changfa Xia

Maomao Cao

Fan Yang

Xinxin Yan

Siyi He

Mengdi Cao

Shaoli Zhang

Qianru Li

Nuopei Tan

Jiachen Wang

Wanqing Chen

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to provide a comprehensive overview of the global burden of esophageal cancer (EC) and determine the temporal trends and factors influencing changes in the global burden.

Methods: The latest incidence and mortality data for EC worldwide were obtained from GLOBALCAN 2022. The mortality and disability-adjusted life years (DALYs) rates for EC from 1990-2019 were sourced from the 2019 Global Burden of Diseases. Trends in EC mortality and DALYs attributable to 11 risk factors or clusters of risk were analyzed using the joinpoint regression model. The trends in age-related EC burden were assessed using a decomposition approach.

Results: An estimated 511,054 new cases of EC were diagnosed in 2022 with 445,391 deaths worldwide. Approximately 75% of cases and deaths occurred in Asia. Nearly 50% of global EC deaths and DALYs were attributed to tobacco use in men in 2019, while 20% were attributed to high body mass index (BMI) in women. From 1990-2019, EC deaths and DALYs attributable to almost all risk factors had declining trends, while EC deaths and DALYs attributed to high BMI in men had upward trends. The age-related EC burden exhibited an upward trend driven by population growth and aging, which contributed to 307.4 thousand deaths and 7.2 million DALYs due to EC.

Conclusions: The EC burden remains substantial worldwide. Effective tobacco and obesity control measures are critical for addressing the risk-attributable burden of EC. Population growth and aging pose challenges for EC prevention and control efforts.

Citing Articles

Association of NR0B1 with Malignant Phenotypes in Esophageal Squamous Cell Carcinoma Through Modulation of p53-Independent Cell-Cycle Regulation.

Iizuka A, Kanda M, Sato Y, Shimizu D, Umeda S, Tanaka H Ann Surg Oncol. 2025; .

PMID: 40080367 DOI: 10.1245/s10434-025-17109-y.

Retrospective Analysis of Dosimetric Comparison Between Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy in Patients With Esophageal Cancer.

Mishra V, Yadav R, Chaudhary S, Pandey L, Pandey A Cureus. 2025; 17(1):e76981.

PMID: 39912037 PMC: 11794999. DOI: 10.7759/cureus.76981.

Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions.

Hasan A, Cavalu S, Kira A, Hamad R, Abdel-Reheim M, Elmorsy E Int J Nanomedicine. 2025; 20():741-770.

PMID: 39845772 PMC: 11752831. DOI: 10.2147/IJN.S502833.

Current status of research on the mechanisms of tumor-associated macrophages in esophageal cancer progression.

Tang Y, Shi T, Lin S, Fang T Front Oncol. 2024; 14:1450603.

PMID: 39678502 PMC: 11638059. DOI: 10.3389/fonc.2024.1450603.

References

Jaacks L, Vandevijvere S, Pan A, McGowan C, Wallace C, Imamura F . The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019; 7(3):231-240. PMC: 7360432. DOI: 10.1016/S2213-8587(19)30026-9. View

Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

Chen Q, Zhuang H, Liu Y . The association between obesity factor and esophageal caner. J Gastrointest Oncol. 2012; 3(3):226-31. PMC: 3418533. DOI: 10.3978/j.issn.2078-6891.2012.026. View

Mackay J, Amos A . Women and tobacco. Respirology. 2003; 8(2):123-30. DOI: 10.1046/j.1440-1843.2003.00464.x. View

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

Lin L, Li Z, Yan L, Liu Y, Yang H, Li H . Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019. J Hematol Oncol. 2021; 14(1):197. PMC: 8607714. DOI: 10.1186/s13045-021-01213-z. View

Sheikh M, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M . Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study. Gastroenterology. 2019; 156(5):1416-1427. PMC: 7507680. DOI: 10.1053/j.gastro.2018.12.024. View

Arnold M, Soerjomataram I, Ferlay J, Forman D . Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014; 64(3):381-7. DOI: 10.1136/gutjnl-2014-308124. View

Maomao C, He L, Dianqin S, Siyi H, Xinxin Y, Fan Y . Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022; 19(8). PMC: 9425189. DOI: 10.20892/j.issn.2095-3941.2022.0231. View

10.

Thrift A . Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021; 18(6):432-443. DOI: 10.1038/s41575-021-00419-3. View

11.

Tarazi M, Chidambaram S, Markar S . Risk Factors of Esophageal Squamous Cell Carcinoma beyond Alcohol and Smoking. Cancers (Basel). 2021; 13(5). PMC: 7957519. DOI: 10.3390/cancers13051009. View

12.

Kroep S, Lansdorp-Vogelaar I, Rubenstein J, Lemmens V, van Heijningen E, Aragones N . Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol. 2013; 109(3):336-43. PMC: 5983360. DOI: 10.1038/ajg.2013.420. View

13.

. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204-1222. PMC: 7567026. DOI: 10.1016/S0140-6736(20)30925-9. View

14.

Andrici J, Eslick G . Hot Food and Beverage Consumption and the Risk of Esophageal Cancer: A Meta-Analysis. Am J Prev Med. 2015; 49(6):952-60. DOI: 10.1016/j.amepre.2015.07.023. View

15.

. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

16.

Morgan E, Soerjomataram I, Rumgay H, Coleman H, Thrift A, Vignat J . The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022; 163(3):649-658.e2. DOI: 10.1053/j.gastro.2022.05.054. View

17.

Choi E, Park H, Lee K, Park J, Eisenhut M, van der Vliet H . Body mass index and 20 specific cancers: re-analyses of dose-response meta-analyses of observational studies. Ann Oncol. 2018; 29(3):749-757. DOI: 10.1093/annonc/mdx819. View

18.

Domper Arnal M, Ferrandez Arenas A, Lanas Arbeloa A . Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015; 21(26):7933-43. PMC: 4499337. DOI: 10.3748/wjg.v21.i26.7933. View

19.

Smyth E, Lagergren J, Fitzgerald R, Lordick F, Shah M, Lagergren P . Oesophageal cancer. Nat Rev Dis Primers. 2017; 3:17048. PMC: 6168059. DOI: 10.1038/nrdp.2017.48. View

20.

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View